Aclaris Therapeutics, Inc. — All Filings
842 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000505 | Mar 26, 2026 | — |
| SCHEDULE 13G | — | 0001172661-26-001355 | Mar 17, 2026 | — |
| 8-K | 8-K | 0001104659-26-026407 | Mar 11, 2026 | Mar 10, 2026 |
| 8-K | 8-K | 0001104659-26-025420 | Mar 10, 2026 | Mar 9, 2026 |
| 4 | — | 0001957554-26-000011 | Mar 3, 2026 | Mar 1, 2026 |
| 10-K | 10-K | 0001104659-26-020540 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001104659-26-020070 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001373604-26-000008 | Feb 9, 2026 | — |
| 4 | — | 0001781549-26-000013 | Feb 6, 2026 | Feb 2, 2026 |
| 4 | — | 0002076327-26-000002 | Feb 6, 2026 | Feb 2, 2026 |
| 4 | — | 0002065269-26-000002 | Feb 6, 2026 | Feb 2, 2026 |
| 4 | — | 0002045027-26-000004 | Feb 6, 2026 | Feb 2, 2026 |
| 4 | — | 0001604457-26-000007 | Feb 6, 2026 | Feb 2, 2026 |
| 4 | — | 0001957554-26-000009 | Feb 6, 2026 | Feb 2, 2026 |
| 4 | — | 0001781549-26-000011 | Feb 5, 2026 | Feb 3, 2026 |
| 4/A | — | 0001781549-26-000009 | Feb 5, 2026 | Feb 1, 2026 |
| 4 | — | 0001957554-26-000007 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | — | 0002045027-26-000002 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | — | 0001604457-26-000005 | Feb 5, 2026 | Feb 3, 2026 |
| 4/A | — | 0001781549-26-000005 | Feb 3, 2026 | Feb 1, 2025 |
| 4 | — | 0001781549-26-000007 | Feb 3, 2026 | Feb 1, 2026 |
| 4 | — | 0001957554-26-000005 | Feb 3, 2026 | Feb 1, 2026 |
| SCHEDULE 13G/A | — | 0002012383-26-000630 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001104659-26-002694 | Jan 12, 2026 | — |
| SCHEDULE 13G/A | — | 0000929638-26-000098 | Jan 9, 2026 | — |
| 8-K | 8-K | 0001104659-26-001076 | Jan 6, 2026 | — |
| 4 | — | 0001604457-26-000003 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | — | 0001957554-26-000003 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001781549-26-000003 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0002045027-25-000003 | Dec 4, 2025 | Dec 2, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-004888 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001104659-25-107353 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001104659-25-107788 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001104659-25-098991 | Oct 14, 2025 | — |
| 8-K | 8-K | 0001558370-25-010640 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-010789 | Aug 7, 2025 | Jun 30, 2025 |
| 3 | — | 0001415889-25-021040 | Aug 5, 2025 | Jul 28, 2025 |
| 4 | — | 0001415889-25-021045 | Aug 5, 2025 | Aug 1, 2025 |
| SCHEDULE 13G | — | 0000932471-25-000787 | Jul 29, 2025 | — |
| 8-K | 8-K | 0001558370-25-009739 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-070388 | Jul 24, 2025 | — |
| SCHEDULE 13G | — | 0002052113-25-002984 | Jul 17, 2025 | — |
| 8-K | 8-K | 0001558370-25-008984 | Jun 30, 2025 | — |
| 4 | — | 0001415889-25-016247 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016248 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016249 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016250 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016251 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016252 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0001558370-25-008430 | Jun 5, 2025 | — |